CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-01 | THERO JOHN F President and CEO | Grant or award · Stock Options (Right to Buy) | +558,000 | $3.80 | $2.1M | 558,000 |
| 2018-02-01 | Salyer Mark Chief Commercial Officer | Grant or award · Restricted Stock Units | +78,000 | 78,000 | ||
| 2018-02-01 | Salyer Mark Chief Commercial Officer | Grant or award · Stock Options (Right to Buy) | +117,000 | $3.80 | $445K | 117,000 |
| 2018-02-01 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Units | +78,000 | 78,000 | ||
| 2018-02-01 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +117,000 | $3.80 | $445K | 117,000 |
| 2018-02-01 | Kennedy Joseph T General Counsel | Grant or award · Restricted Stock Units | +78,000 | 78,000 | ||
| 2018-02-01 | Kennedy Joseph T General Counsel | Grant or award · Stock Option (Right to Buy) | +117,000 | $3.80 | $445K | 117,000 |
| 2018-02-01 | Kalb Michael Wayne SVP and CFO | Grant or award · Restricted Stock Units | +78,000 | 78,000 | ||
| 2018-02-01 | Kalb Michael Wayne SVP and CFO | Grant or award · Stock Option (Right to Buy) | +117,000 | $3.80 | $445K | 117,000 |
| 2018-01-31 | THERO JOHN F President and CEO | Option exercise | +260,000 | 1,416,771 | ||
| 2018-01-31 | THERO JOHN F President and CEO | Option exercise | +120,000 | 1,536,771 | ||
| 2018-01-31 | THERO JOHN F President and CEO | Option exercise | +119,667 | 1,656,438 | ||
| 2018-01-31 | THERO JOHN F President and CEO | Shares withheld for taxes | −197,513 | $3.83 | $756K | 1,458,925 |
| 2018-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −260,000 | 0 | ||
| 2018-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −120,000 | 120,000 | ||
| 2018-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −119,667 | 239,333 | ||
| 2018-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +60,937 | 202,734 | ||
| 2018-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +26,667 | 229,401 | ||
| 2018-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +29,000 | 258,401 | ||
| 2018-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −57,428 | $3.83 | $220K | 200,973 |
Page 86 of 95 · 1,885 trades